Perfect Medical Industry Co., Ltd. (TPEX:6543)
Taiwan · Delayed Price · Currency is TWD 18.25
+0.05 (0.27%)
Jul 30, 2026, 12:51 PM CST
Perfect Medical Industry Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,017 | 1,592 | 1,498 | 842 | 744 | 772 | |
Market Cap Growth | -37.02% | 6.25% | 77.84% | 13.19% | -3.57% | -30.02% |
Enterprise Value | 1,098 | 1,602 | 1,398 | 906 | 891 | 879 |
Last Close Price | 18.20 | 27.81 | 26.94 | 16.37 | 14.16 | 16.04 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.16 | 29.35 | 16.81 | 21.02 | 52.16 | 19.91 |
PS Ratio | 1.30 | 2.04 | 2.01 | 1.15 | 1.10 | 1.07 |
PB Ratio | 1.24 | 1.93 | 1.86 | 1.27 | 1.15 | 1.34 |
P/TBV Ratio | 1.24 | 1.95 | 1.87 | 1.27 | 1.15 | 1.34 |
P/FCF Ratio | - | - | 32.18 | 9.89 | 14.08 | - |
P/OCF Ratio | 9.45 | 14.79 | 10.44 | 5.62 | 7.05 | 173.72 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.41 | 2.06 | 1.88 | 1.23 | 1.32 | 1.21 |
EV/EBITDA Ratio | 9.24 | 14.09 | 9.86 | 8.38 | 17.29 | 8.75 |
EV/EBIT Ratio | 21.36 | 31.17 | 15.32 | 15.52 | 244.08 | 15.10 |
EV/FCF Ratio | - | - | 30.02 | 10.63 | 16.86 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.42 | 0.42 | 0.23 | 0.31 | 0.32 | 0.56 |
Debt / EBITDA Ratio | 2.92 | 2.92 | 1.25 | 1.81 | 3.48 | 3.01 |
Debt / FCF Ratio | - | - | 3.95 | 2.45 | 3.91 | - |
Net Debt / Equity Ratio | 0.10 | 0.10 | -0.07 | 0.04 | 0.18 | 0.35 |
Net Debt / EBITDA Ratio | 0.72 | 0.72 | -0.39 | 0.26 | 2.21 | 2.00 |
Net Debt / FCF Ratio | -0.92 | -0.92 | -1.19 | 0.33 | 2.16 | -2.04 |
Asset Turnover | 0.63 | 0.63 | 0.71 | 0.76 | 0.68 | 0.73 |
Inventory Turnover | 2.90 | 2.90 | 2.88 | 3.20 | 2.59 | 2.50 |
Quick Ratio | 1.04 | 1.04 | 1.84 | 1.04 | 1.00 | 0.57 |
Current Ratio | 1.71 | 1.71 | 3.01 | 1.72 | 2.11 | 1.33 |
Return on Equity (ROE) | 6.67% | 6.67% | 12.14% | 6.11% | 2.33% | 6.70% |
Return on Assets (ROA) | 2.61% | 2.61% | 5.42% | 3.75% | 0.23% | 3.68% |
Return on Invested Capital (ROIC) | 4.31% | 4.72% | 10.51% | 5.92% | 0.38% | 5.10% |
Return on Capital Employed (ROCE) | 5.40% | 5.40% | 9.80% | 8.20% | 0.50% | 9.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.34% | 3.41% | 5.95% | 4.76% | 1.92% | 5.02% |
FCF Yield | -8.70% | -5.56% | 3.11% | 10.11% | 7.10% | -12.81% |
Dividend Yield | 1.09% | 0.72% | 5.57% | 4.28% | 2.61% | 1.97% |
Payout Ratio | 84.46% | 84.46% | 73.09% | 42.14% | 101.10% | 151.58% |
Buyback Yield / Dilution | -12.08% | -12.08% | -11.20% | -3.98% | -8.91% | 2.73% |
Total Shareholder Return | -10.99% | -11.36% | -5.64% | 0.29% | -6.30% | 4.70% |